James W. Beattie
James W. Beattie publishes mostly in Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology, on topics such as Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research and Chemical Synthesis and Analysis.
- World rank
- #4,650,158 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #285,931 of 367,258
- Works
- 39
- Citations
- 674
- Citations per work
- 17.3
What does James W. Beattie research?
James W. Beattie's work is mostly in Biochemistry, Genetics and Molecular Biology (30%), Medicine (21%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1948.8%
- Life Sciences1230.2%
- Health Sciences821.0%
- Medicine821.0%
- 1Molecular Biology25% of their works
- 2Endocrinology, Diabetes and Metabolism6% of their works
- 3Oncology6% of their works
- 4Genetics5% of their works
- 5Public Health, Environmental and Occupational Health4% of their works
- 6Radiology, Nuclear Medicine and Imaging4% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- Glycosylation and Glycoproteins Research
- Chemical Synthesis and Analysis
- Protein Kinase Regulation and GTPase Signaling
- Phosphodiesterase function and regulation
- Connective Tissue Growth Factor Research
- Growth Hormone and Insulin-like Growth Factors
- Cancer Cells and Metastasis
Which keywords describe James W. Beattie's research?
The keywords of their largest research topics: Glycosylation, Cancer, Fc Receptors, Therapeutic Antibodies, cAMP Signaling, Cancer Stem Cells, CCN Family and Connective Tissue Growth Factor.
- cAMP Signaling
- Ras Signaling
- Peptide Synthesis
- Immune System
- Glycans
- Cyclic Nucleotide Phosphodiesterases
- Cancer Stem Cells
- Therapeutic Antibodies
- Cancer
- Glycosylation
- Fc Receptors
- CCN Family
- Connective Tissue Growth Factor
- Drug Discovery
- IGF-1
- Insulin-like Growth Factors
- Protein Kinases
- Tumor Metastasis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Glycosylation72 topics
- Cancer62 topics
- Fc Receptors41 topic
- Therapeutic Antibodies41 topic
- CCN Family31 topic
- Cancer Stem Cells31 topic
- Connective Tissue Growth Factor31 topic
- Cyclic Nucleotide Phosphodiesterases31 topic
- Drug Discovery31 topic
- Glycans31 topic
- IGF-131 topic
- Immune System31 topic
- Insulin-like Growth Factors31 topic
- Peptide Synthesis31 topic
- Protein Kinases31 topic
- Ras Signaling31 topic
- Tumor Metastasis31 topic
- cAMP Signaling31 topic
Where does James W. Beattie work?
James W. Beattie's main affiliation in the publication record is Hannah Research Foundation, United Kingdom.
How many publications and citations does James W. Beattie have?
OpenAlex counts 39 works and 674 citations for James W. Beattie, an h-index of 12, ranking #4,650,158 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about James W. Beattie. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.